Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

40 results about "Phosphoglucomutase" patented technology

Phosphoglucomutase (EC 5.4.2.2) is an enzyme that transfers a phosphate group on an α-D-glucose monomer from the 1' to the 6' position in the forward direction or the 6' to the 1' position in the reverse direction.

Method for preparing cordyceps militaris polysaccharide through multi-gene combined expression

The invention discloses a method for preparing cordyceps militaris polysaccharide through multi-gene combined expression. The method comprises the following steps of introducing a combined gene into cordyceps militaris cells to construct recombinant cordyceps militaris genetically engineered bacteria, inoculating the recombinant cordyceps militaris genetically engineered bacteria into a fermentation culture medium, and carrying out fermentation culture at 22-25 DEG C at 100-150 rpm to obtain a fermentation liquor comprising cordyceps militaris polysaccharide; carrying out separating and purifying on the fermentation liquor to obtain the cordyceps militaris polysaccharide, wherein the combined gene is a combination of any two of a phosphoglucose mutase gene pgm, a pyrophosphorylase gene ugpor a UDP-glucose-6-dehydrogenase gene ugdh. The recombinant cordyceps militaris genetically engineered bacteria are constructed through a gene combination expression technology, and compared with a wild strain, the yield of cordyceps militaris exopolysaccharides in fermentation liquor of the genetically engineered bacteria is 1.78 times and is 5.713 g/L higher than the maximum yield of cordycepsmilitaris exopolysaccharides produced by fermentation reported in literatures at present.
Owner:ZHEJIANG UNIV OF TECH

glmm gene knock-out bacterial strain as well as preparation method and application in sieving mycobacterium tuberculosis phosphoglucomutase inhibitors

The invention discloses a glmM gene knock-out bacterial strain ML2009 (mycobacterium smegmatis), CGMCC (China General Microbiological Culture Collection Center) 3418, which is constructed by using phosphoglucomutase participating in the biosynthesis of key components in a mycobacterium tuberculosis cell wall. The bacterial strain ML2009 can be used as a cell model for sieving phosphoglucomutase inhibitors with high flux, be used for sieving effective phosphoglucomutase inhibitors from a combined compound library, traditional Chinese medicine and natural products to prepare tuberculosis-resisting medicaments with high medicine effects; and in addition, in the cells of a human body, the synthesis approach of UDP (Uridine Diphosphate)-acetyl glucosamine is different from that of mycobacterium tuberculosis, no phosphoglucomutase exists in the UDP-acetyl glucosamine, therefore, the reaction catalyzed by the mycobacterium tuberculosis phosphoglucomutase does not exist in the cells of the human body so that the tuberculosis-resisting medicaments developed by using the phosphoglucomutase as a target enzyme are harmless to the human body, and the defect that the traditional antibacterial medicament also kill normal cells is overcome.
Owner:DALIAN MEDICAL UNIVERSITY

Engineering bacteria for over-expressing phosphoglucomutase gene and uridine diphosphate glucose pyrophosphorylase gene and construction method

InactiveCN106916776AIncrease productionLow costBacteriaMicroorganism based processesBacillus licheniformisUridine diphosphate glucose pyrophosphorylase
Engineering bacteria for over-expressing a phosphoglucomutase gene and a uridine diphosphate glucose pyrophosphorylase gene and a construction method. The invention relates to gene engineering and microbial fermentation and discloses a strain of bacillus licheniformis, which simultaneously over-expressing a phosphoglucomutase gene (pgcA) and a UDP-glucose pyrophosphorylase gene (gtaB1), and the construction method thereof. In the method, the genes of the phosphoglucomutase and the UDP-glucose pyrophosphorylase, which are key enzymes in a synthesis route of a polysaccharide flocculating agent, are cloned, and a recombinant expression vector is constructed through escherichia coli-bacillus shuttle plasmid. Through an electrotransformation method, a recombinant plasmid is introduced into the bacillus licheniformis, thereby constructing a recombinant bacillus licheniformis strain HN301-5. The recombinant bacillus licheniformis is increased in yield of the polysaccharide flocculating agent by 20.77% than that of an original strain, and is hopeful to be applied in industrial production of the polysaccharide flocculating agent, thereby increasing yield and reducing cost.
Owner:XIAMEN UNIV

Escherichia coli recombinant bacterium for synthesizing inositol by efficiently utilizing glucose as well as construction method and application of escherichia coli recombinant bacterium

The invention discloses an escherichia coli recombinant bacterium for synthesizing inositol by efficiently utilizing glucose as well as a construction method and application of the escherichia coli recombinant bacterium. The construction method of the escherichia coli recombinant bacterium for producing the inositol, provided by the invention, comprises the steps: introducing an inositol-3-phosphate synthetase gene and an inositol monophosphate enzyme gene into host bacteria to obtain the escherichia coli recombinant bacteria for producing the inositol, wherein the host bacteria are wild escherichia coli or mutant escherichia coli; and the mutant escherichia coli is obtained by knocking out a glucose-6-phosphate isomerase gene or a glucophosphomutase gene or a glucose-6-phosphate dehydrogenase gene in an SG104 genome of the mutant escherichia coli. Glucose can be efficiently utilized to synthesize the inositol by utilizing the escherichia coli recombinant strain for producing the inositol, and the yield of the inositol can be up to 375 mM (67.5 g/L). For inositol production, huge economic benefits can be generated, and the method has great popularization and application values.
Owner:INST OF MICROBIOLOGY - CHINESE ACAD OF SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products